# Cardiac Organoid Field Landscape

## Major Research Labs

### Tier 1: Field Leaders (Start Here)

**Mendjan Lab** — IMBA Vienna, Austria
- **PI**: Sasha Mendjan
- **Focus**: Self-organizing cardioids with chamber morphogenesis
- **Key innovation**: First chamber-forming cardiac organoids without scaffolds
- **Signature approach**: Temporal signaling modulation (WNT, BMP, FGF, RA, Activin)
- **Best for**: Developmental biology, congenital defects, chamber formation
- **Spinoff**: HeartBeat.bio (drug discovery)
- **Search terms**: "Mendjan cardioid", "IMBA cardiac organoid", "Hofbauer cardioid"

**Aguirre Lab** — Michigan State University, USA
- **PI**: Aitor Aguirre
- **Focus**: Self-assembling heart organoids for developmental modeling
- **Key innovation**: 96-well reproducible protocol matching fetal heart transcriptome
- **Signature approach**: Three-step Wnt modulation, metabolic/hormonal factors
- **Best for**: Congenital heart disease, diabetes effects, developmental studies
- **Search terms**: "Aguirre heart organoid", "Lewis-Israeli cardiac", "MSU heart organoid"

**Mills/Hudson Lab** — QIMR Berghofer & Murdoch Children's, Australia
- **PIs**: Richard J. Mills, James E. Hudson, Enzo R. Porrello
- **Focus**: Cardiomyocyte maturation and functional disease modeling
- **Key innovation**: AMPK/ERR-driven maturation; Heart-Dyno platform
- **Signature approach**: Directed assembly + metabolic maturation + mechanical loading
- **Best for**: Drug screening, cardiomyopathies, arrhythmias, adult disease
- **Spinoff**: Dynomics
- **Search terms**: "Mills cardiac organoid", "Hudson heart organoid", "QIMR cardiac", "Heart-Dyno"

### Tier 2: Important Contributors

**Bhattacharya Lab** — UCLA / Cedars-Sinai, USA
- **Focus**: Early cardiac organoid protocols, vascularization
- **Known for**: Diabetes effects on cardiac development

**Vunjak-Novakovic Lab** — Columbia University, USA
- **Focus**: Bioreactor systems, electromechanical maturation
- **Known for**: Combined pacing + mechanical loading approaches

**Wu Lab** — Stanford University, USA
- **PI**: Joseph Wu
- **Focus**: iPSC-derived cardiomyocytes, clinical translation
- **Known for**: Patient-specific disease modeling, cardiotoxicity

**Bhattacharyya Lab** — Northwestern, USA
- **Focus**: Vascularized cardiac organoids

**Kwon Lab** — Johns Hopkins, USA
- **Focus**: Heart organoid development, tissue models

**Radisic Lab** — University of Toronto, Canada
- **Focus**: Organ-on-chip, Biowire platform
- **Known for**: Microfluidic cardiac systems

## Methodological Camps

### 1. Self-Organizing Organoids
**Philosophy**: Let cells self-organize via developmental signaling
**Leaders**: Mendjan, Aguirre
**Advantages**:
- More physiological structure
- Chamber/cavity formation
- Mimics embryonic development
**Limitations**:
- Limited maturation (fetal stage)
- Variable morphology
- Harder to control cell ratios

### 2. Directed Assembly / Engineered Heart Tissues
**Philosophy**: Assemble cells with scaffolds/matrices for controlled structure
**Leaders**: Mills/Hudson, Vunjak-Novakovic, Radisic
**Advantages**:
- Better functional maturation
- Reproducible mechanical properties
- Drug screening compatible
**Limitations**:
- No chamber formation
- Less physiological structure
- Requires exogenous matrices

### 3. Organ-on-Chip / Microphysiological Systems
**Philosophy**: Microfluidic platforms with perfusion and sensors
**Leaders**: Radisic (Biowire), various bioengineering groups
**Advantages**:
- Real-time monitoring
- Multi-organ integration
- Perfusable systems
**Limitations**:
- Complex fabrication
- Limited cell numbers
- Expensive

## Active Debates in the Field

### Maturation: What's "Mature Enough"?
- **Question**: What metrics define sufficient maturation for disease modeling?
- **Camps**:
  - Structural (sarcomere organization, T-tubules)
  - Functional (force, calcium handling, drug response)
  - Metabolic (fatty acid oxidation, oxygen consumption)
  - Transcriptomic (adult gene signatures)
- **Current status**: No consensus; Mills/Hudson argue functional readouts most important

### Chamber Formation vs. Functional Maturation
- **Question**: Can we have both chamber structure AND adult function?
- **Tension**: Mendjan organoids have chambers but fetal maturity; Mills organoids are more mature but no chambers
- **Gap**: Combining approaches not yet achieved

### Vascularization Strategies
- **Approaches**:
  - Endothelial co-culture (Voges et al.)
  - VEGF addition
  - Microfluidic perfusion
  - Self-organizing vasculature
- **Debate**: Is functional perfusion necessary or is paracrine signaling sufficient?

### Immune Cell Integration
- **Question**: Should cardiac organoids include macrophages?
- **Arguments for**: Critical for fibrosis, inflammation, regeneration
- **Arguments against**: Adds complexity, not needed for all applications
- **Current status**: Very few groups doing this

### Electrical Pacing
- **Question**: Is pacing essential for maturation?
- **Findings**: Pacing improves function but causes toxicity in some systems
- **Workarounds**: Chemical pacing mimetics (AMPK activation), optogenetics

## Key Journals (Priority Order)

### Top Tier (Check First)
- Cell
- Nature
- Nature Cardiovascular Research
- Nature Communications
- Cell Stem Cell
- Circulation

### High Quality
- Cell Reports
- Stem Cell Reports
- PNAS
- Circulation Research
- Cardiovascular Research

### Preprints (Cutting Edge)
- bioRxiv (Developmental Biology, Cell Biology sections)
- medRxiv (for clinical applications)

### Methods/Protocols
- Nature Protocols
- STAR Protocols
- Current Protocols
- Journal of Visualized Experiments (JoVE)

## Current Hot Topics (2024-2025)

1. **Multi-chamber organoids** — Mendjan's 2023 Cell paper opened this area
2. **Maturation cocktails** — AMPK, ERR, metabolic approaches gaining traction
3. **Disease-specific organoids** — DSP cardiomyopathy, arrhythmias, CHD
4. **Drug screening validation** — CiPA compound testing, cardiotoxicity
5. **AI/imaging integration** — OCT imaging, machine learning for phenotyping
6. **Immune-cardiac interactions** — Emerging but still limited

## Quick Reference: Lab → Application

| Application | Best Lab(s) to Search |
|-------------|----------------------|
| Chamber development | Mendjan |
| Congenital heart defects | Mendjan, Aguirre |
| Diabetes/metabolic effects | Aguirre |
| Drug screening | Mills/Hudson |
| Cardiomyopathy modeling | Mills/Hudson |
| Arrhythmia | Mills/Hudson, Bhattacharya |
| Maturation protocols | Mills/Hudson |
| Vascularization | Voges (Mills/Hudson group), Bhattacharyya |
| Methods/protocols | All three Tier 1 labs have detailed protocols |

## Search Strategy by Topic

| Topic | Search Terms |
|-------|--------------|
| General field | "cardiac organoid review 2024" |
| Maturation | "cardiac organoid maturation" + Mills OR Hudson OR AMPK |
| Chambers | "cardioid chamber" OR "multi-chamber heart organoid" + Mendjan |
| Disease modeling | "cardiac organoid [disease name]" |
| Drug screening | "cardiac organoid drug screening" OR "cardiotoxicity organoid" |
| CHD | "heart organoid congenital" + Aguirre OR Mendjan |
| Vascularization | "cardiac organoid vascular" OR "vascularized heart organoid" |
| Methods | "[lab name] cardiac organoid protocol" OR site:protocols.io |
